SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jargonweary who wrote (62821)9/18/2024 5:37:35 PM
From: Fitzhughlaw4 Recommendations

Recommended By
erippetoe
jargonweary
jhcimmu
urslor

   of 63326
 
You're correct, but it also makes him part of the "control group" for the purposes of asserting attorney-client privilege, and the shield afforded by attorney work product. The control group test for attorney-client privilege is a restrictive one not used in a majority of jurisdictions, but this agreement will likely afford protection even if it's applied in any litigation, whether based in Texas or any other state.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News